NEW YORK (GenomeWeb News) – Cardiff University in Wales will invest £10 million ($14.8 million) into three new multidisciplinary research institutes.
The first among these is the Cancer Stem Cell Research Institute, which aims to conduct studies that will lead to new cancer therapies. The institute said it plans to create and grow 11 research groups that will investigate the most common types of cancer, including blood, skin, colon, breast, lung, prostate, pancreatic and urological. The groups will consist of "key international players in fundamental science, translational science and clinical trials," the institute said on its website.
The institute's director will be Alan Clarke, who has recently been appointed leader of the new Pathophysiology and Repair Research Division at Cardiff's School of Biosciences. Clarke is also director of the Cardiff Cancer Research UK Centre, a partnership of Cancer Research UK, Cardiff University, Velindre NHS Trust and Cardiff and Vale University Health Board.
The institute will share the building with another new institute announced by the university. The Neurosciences and Mental Health Research Institute has been formed to translate Cardiff's basic research in psychiatric and neurodegenerative disorders into a greater understanding of disease mechanisms, classification, and diagnosis. Among research areas will be attention deficit hyperactivity disorder, autism, bipolar disorder, schizophrenia, and neurodegenerative disorders such as Alzheimer's disease, Huntington's disease and Parkinson's disease.
The third institute — the Sustainable Places Research Institute — will focus on developing environmentally sustainable solutions for cities and their surrounding regions.